Difference between revisions of "Part:BBa K4165142"
(5 intermediate revisions by one other user not shown) | |||
Line 3: | Line 3: | ||
<partinfo>BBa_K4165142 short</partinfo> | <partinfo>BBa_K4165142 short</partinfo> | ||
− | + | A synthetic peptide that is used for targeting misfolded tau protein (BBa_K4165009) as it binds to PHF6 of tau fibrils. | |
− | |||
===Usage and Biology=== | ===Usage and Biology=== | ||
− | + | MMD3rev peptide (YWVSTHRAKLPD) acquired by mirror image phage display, it binds to 275-VQIINK-280 (PHF*) and 306-VQIVYK-311 (PHF) motifs of tau that are reported to drive tau paired helical filament aggregates. It inhibits formation of PHF6* and full‐length Tau aggregates, but not PHF driven aggregates, and prevents the formation of tau β‐sheet‐rich fibrils. | |
− | <span class='h3bb'>Sequence and Features</span> | + | |
+ | <span class='h3bb'> <p style=" font-weight: bold; font-size:17px;"> Sequence and Features</p> </span> | ||
<partinfo>BBa_K4165142 SequenceAndFeatures</partinfo> | <partinfo>BBa_K4165142 SequenceAndFeatures</partinfo> | ||
+ | |||
+ | |||
+ | ===Dry Lab=== | ||
+ | <p style=" font-weight: bold; font-size:14px;"> Modeling </p> | ||
+ | MMD3rev is modeled by AlphaFold2, Apptest, ITASSER and TrRosetta, best model obtained from ITASSER. | ||
+ | |||
+ | |||
+ | |||
+ | <html> | ||
+ | <p><img src="https://static.igem.wiki/teams/4165/wiki/parts-registry/mmd3rev.png" style="margin-left:300px;" alt="" width="300" /></p> | ||
+ | </html> | ||
+ | |||
+ | Figure 1.: Predicted 3D structure of Synthetic peptide MMD3rev. | ||
+ | |||
+ | |||
+ | |||
+ | <p style=" font-weight: bold; font-size:13px;"> Table 1: Quality assessment parameters of MMD3rev model. </p> | ||
+ | |||
+ | <html> | ||
+ | <p><img src="https://static.igem.wiki/teams/4165/wiki/parts-registry/mmd3rev-qa.png" style="margin-left:50px;" alt="" width="800" /></p> | ||
+ | </html> | ||
+ | |||
+ | |||
+ | ===References=== | ||
+ | 1. Malhis, M., Kaniyappan, S., Aillaud, I., Chandupatla, R. R., Ramirez, L. M., Zweckstetter, M., ... & Funke, S. A. (2021). Potent Tau Aggregation Inhibitor D‐Peptides Selected against Tau‐Repeat 2 Using Mirror Image Phage Display. ChemBioChem, 22(21), 3049-3059. | ||
Latest revision as of 12:27, 11 October 2022
MMD3rev Peptide
A synthetic peptide that is used for targeting misfolded tau protein (BBa_K4165009) as it binds to PHF6 of tau fibrils.
Usage and Biology
MMD3rev peptide (YWVSTHRAKLPD) acquired by mirror image phage display, it binds to 275-VQIINK-280 (PHF*) and 306-VQIVYK-311 (PHF) motifs of tau that are reported to drive tau paired helical filament aggregates. It inhibits formation of PHF6* and full‐length Tau aggregates, but not PHF driven aggregates, and prevents the formation of tau β‐sheet‐rich fibrils.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Dry Lab
Modeling
MMD3rev is modeled by AlphaFold2, Apptest, ITASSER and TrRosetta, best model obtained from ITASSER.
Figure 1.: Predicted 3D structure of Synthetic peptide MMD3rev.
Table 1: Quality assessment parameters of MMD3rev model.
References
1. Malhis, M., Kaniyappan, S., Aillaud, I., Chandupatla, R. R., Ramirez, L. M., Zweckstetter, M., ... & Funke, S. A. (2021). Potent Tau Aggregation Inhibitor D‐Peptides Selected against Tau‐Repeat 2 Using Mirror Image Phage Display. ChemBioChem, 22(21), 3049-3059.